Answers are grounded in this paper and cite their sources.
Evaluates neflamapimod treatment effects on basal forebrain atrophy in dementia, suggesting potential benefits.
To evaluate MRI’s potential to assess treatment effects, and assess the impact of neflamapimod treatment, on basal forebrain atrophy.
No takes yet. Share an insight, caveat, or question.
Alam et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: